Futura Medical plc logo

Futura Medical plc (FAMDF)

Market Open
15 Jun, 13:30
OTC PINK OTC PINK
$
0. 03
+0
+0.6711%
$
3.05M Market Cap
- P/E Ratio
- Div Yield
163 Volume
0 Eps
$ 0.03
Previous Close
Add Transaction
Day Range
0.03 0.03
Year Range
0 0.2
Want to track FAMDF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FAMDF trading today higher at $0.03, an increase of 0.6711% from yesterday's close, completing a monthly increase of 200% or $0.02. Over the past 12 months, FAMDF stock gained 200%.
FAMDF is not paying dividends to its shareholders.
The last earnings report, released on Apr 15, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Futura Medical plc has completed 1 stock splits, with the recent split occurring on Oct 22, 2018.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on LSE (GBX).

FAMDF Chart

People also search for

NDT Pharmaceuticals Inc.
$ 0.53
-6.1883%
VicapSys Life Sciences Inc.
$ 1.46
0%
Medigene AG
$ 2.59
0%
Quantumzyme Corp.
$ 0.8
+33.3333%
Positive Physicians Holdings, Inc.
$ 8.5
0%

Futura Medical plc (FAMDF) FAQ

What is the stock price today?

The current price is $0.03.

On which exchange is it traded?

Futura Medical plc is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is FAMDF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.05M.

Has Futura Medical plc ever had a stock split?

Futura Medical plc had 1 splits and the recent split was on Oct 22, 2018.

Futura Medical plc Profile

Biotechnology Industry
Healthcare Sector
Alex Duggan CEO
OTC PINK Exchange
GB0033278473 ISIN
GB Country
14 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Futura Medical plc is a pioneering pharmaceutical company based in Guildford, the United Kingdom, established in 2001. The company is dedicated to developing innovative pharmaceutical and healthcare products with a primary focus on sexual health and pain relief management. Aimed at the consumer healthcare markets, Futura Medical combines scientific rigor with consumer needs to provide solutions that enhance well-being and quality of life.

Products and Services

  • MED3000 - A leading product of Futura Medical, MED3000, is a topically applied gel designed for the treatment of erectile dysfunction. This innovative treatment offers a non-invasive method to help improve sexual health and performance.
  • TPR100 - This product is a topical pain relief gel formulated with diclofenac, aimed at providing relief from various forms of musculoskeletal pain. TPR100 utilizes advanced technology to ensure effective pain management for users seeking non-oral treatment options.
  • CBD100 - A topical cannabidiol formulation developed to harness the therapeutic properties of CBD. CBD100 is designed for users looking for natural pain relief and anti-inflammatory benefits, presenting an alternative approach to pain management.
  • TIB200 - Another pain relief solution offered by Futura Medical, TIB200 is a topical gel containing ibuprofen. It aims to provide fast and effective relief from pain and inflammation, suitable for individuals requiring immediate pain management solutions.

Contact Information

Address: Surrey Technology Centre
Phone: 44 14 8368 5670